ADMA Biologics, Inc.ADMANASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Percentile
P100
Near historical high
vs 2Y Ago
19.6x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM38.78%+12.0%
202434.63%+1646.6%
20231.98%+107.7%
2022-25.64%+60.9%
2021-65.60%+53.7%
2020-141.69%-15.4%
2019-122.76%+63.3%
2018-334.26%-93.5%
2017-172.71%-9.6%
2016-157.64%-